Cyclic,low-dose total body irradiation for metastatic neuroblastoma |
| |
| Authors: | Giulio J. D&#x Angio,Audrey E. Evans |
| |
| Affiliation: | 1. Professor of Radiation Therapy and Professor of Pediatric Oncology, `Professor of Pediatrics, Departments of Radiation Therapy and Pediatrics, University of Pennsylvania and the Children''s Cancer Research Center, Children''s Hospital of Philadelphia, Philadelphia, PA, USA;2. Professor of Pediatrics, Departments of Radiation Therapy and Pediatrics, University of Pennsylvania and the Children''s Cancer Research Center, Children''s Hospital of Philadelphia, Philadelphia, PA, USA |
| |
| Abstract: | Total body irradiation (TBI) can be thought of as a systemic anticancer agent. It therefore might best be given like an adjuvant drug, i.e. in tolerable doses, cyclically. The therapeutic ratio between normal bone marrow stem cells and suitably sensitive cancer cells should be widened by these means. Fourteen children with advanced (Stage IV) neuroblastomas were given 100–150 rad TBI in 50 rad daily fractions along with each three-week cycle of standard triple-agent chemotherapy (vincristine, DTIC, cyclophosphamide). Two patients died of toxicity and one is still undergoing therapy. Four of the remaining 12 survive free of disease for 12+ to 31 + months. The regimen is well tolerated, but prolonged, pronounced bone marrow depression, especially thrombocytopenia, commonly occurs after doses of 300–450 rad. |
| |
| Keywords: | Advanced neuroblastoma Fractionated TBI Cyclic TBI |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
